Expediting Clinical Trials, Market Access Were Core 2025 Policy Themes In China

 
• By Xu Hu
  
perspectives 2026
Road signs showing 2025 and 2026
China's efforts to toughen regulations and speed up market access for innovative medicines look set to continue in the new year (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from China

More from Pink Sheet Perspectives